Evidence map›Paper›PMID 41125348›Full record

ArticleIndustrial health2026

Work-related health issues among pharmacists during the COVID-19 pandemic compared to pre-pandemic levels.

Tomoko Suzuki, Shoko Satake, Yuko Yoshioka, Kouji Hamada, Shigeo Yamamura, Toru Sato, Shunya Ikeda

Abstract read
In one paragraph

Article in Industrial health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tomoko SuzukiDepartment of Public Health, School of Medicine, International University of Health and Welfare, Japan.
Shoko SatakePractical Training Center of Pharmacy, Yokohama University of Pharmacy, Japan.
Yuko YoshiokaJapanese Association for Community Pharmacy, Japan.
Kouji HamadaApocreat Inc., Japan.
Shigeo YamamuraFaculty of Pharmaceutical Sciences, Josai International University, Japan.
Toru SatoPractical Training Center of Pharmacy, Yokohama University of Pharmacy, Japan.
Shunya IkedaDepartment of Public Health, School of Medicine, International University of Health and Welfare, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pharmacists are at high risk of infection due to their direct contact with potentially infected patients and customers during the COVID-19 pandemic. This study aimed to examine whether increased health issues among pharmacists during the pandemic were associated with pandemic-related changes in their work environment. A total of 438 pharmacists from 28 prefectures completed a self-administered survey between September 2021 and January 2022. Health issues with significant increases among pharmacists during the COVID-19 pandemic included depression, anxiety or emotional disorders, insomnia, eye problems and skin disorders. The following work-related factors were significantly associated with these health issues: For depression, anxiety, or emotional disorders, key factors were fear of infection during medication explanations to customers or patients and fear of infection related to work in general. Insomnia was significantly associated with shift adjustments and fear of infection when fatigued. Eye problems were linked to remote medication counseling via telephone or online platforms, disinfection and cleaning tasks, and shift adjustments. No significant work-related factors were associated with skin disorders. This study identified specific work-related tasks associated with increased health issues, offering valuable insights into the occupational risks faced by pharmacists and informing preparedness for future pandemics.

Indexed as

COVID-19Occupational DiseasesOccupational HealthPharmacistsAdultAnxietyDepressionFemaleFrontline WorkersHumansMaleMiddle AgedPandemicsSARS-CoV-2Surveys and QuestionnairesWorking ConditionsCOVID-19Health issuesOccupational healthPharmacistsWork-related health issues

Identifiers

PMID41125348
PMCPMC13387841

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.